Global Petroleum-Based Needle Coke Industry Report 2021 with Focus on the Chinese Market – ResearchAndMarkets.com

5 years ago

DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Petroleum-Based Needle Coke Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com's offering.…

Shipment of Apple’s Mini LED iPad Pro Expected to Reach Five Million Units in 2021 Thanks to Improved Display Technology, Says TrendForce

5 years ago

TAIPEI, Taiwan--(BUSINESS WIRE)--#FALD--During Apple�s Spring Loaded event, the Cupertino company announced the upcoming release of its latest 12.9-inch iPad Pro…

5 years ago

DALLAS, April 21, 2021 (GLOBE NEWSWIRE) -- Dave & Buster�s Entertainment, Inc. (NASDAQ:PLAY) (the �Company�), an owner and operator of…

5 years ago

WALL, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access…

Stock Yards Bancorp Reports Record First Quarter Earnings of $22.7 Million or $0.99 per Diluted Share

5 years ago

Quarter Highlighted by Agreement to Acquire Kentucky Bancshares LOUISVILLE, Ky., April 21, 2021 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc.…

5 years ago

- Raises Seed Funding to Continue Growth in the Smart Building Access Control Market - SAN JOSE, Calif.--(BUSINESS WIRE)--#Buildingaccesscontrol--SaaS-based physical…

Renesas and SiFive Partner to Jointly-Develop Next-Generation High-End RISC-V Solutions for Automotive Applications

5 years ago

SiFive to License Industry-Leading RISC-V Core IP Portfolio to Renesas TOKYO & SAN MATEO, Calif.--(BUSINESS WIRE)--#Renesas--Renesas Electronics Corporation (TSE:6723), a…

Dr. Norio Komatsu Appointed as a Chairperson of PharmaEssentia Japan

5 years ago

Renowned expert in myeloproliferative neoplasms (MPNs) research joins to guide development efforts and accelerate progress for patient community BURLINGTON, Mass.--(BUSINESS…

Cisco AppDynamics Expands Global Software-as-a-Service Offering With Five New Locations

5 years ago

News Summary: The addition of five new locations across Africa, Asia, Europe and South America brings the total number of…

Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B

5 years ago

� New combination trial of an RNA-targeted therapeutic candidate and an HBV immunotherapeutic candidate aimed at delivering a functional cure…